B & T Capital Management Dba Alpha Capital Management Regeneron Pharmaceuticals, Inc. Transaction History
B & T Capital Management Dba Alpha Capital Management
- $500 Million
- Q1 2025
A detailed history of B & T Capital Management Dba Alpha Capital Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, B & T Capital Management Dba Alpha Capital Management holds 3,510 shares of REGN stock, worth $1.8 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
3,510
Previous 3,147
11.53%
Holding current value
$1.8 Million
Previous $2.24 Million
0.67%
% of portfolio
0.44%
Previous 0.44%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.83 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.34 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.91 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.46 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.05 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $55.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...